OptiNose Q2 2024 GAAP EPS $(0.05) Beats $(0.08) Estimate, Sales $20.490M Miss $20.582M Estimate
Portfolio Pulse from Benzinga Newsdesk
OptiNose (NASDAQ:OPTN) reported Q2 2024 GAAP EPS of $(0.05), beating the $(0.08) estimate, but missed sales estimates with $20.490M versus $20.582M expected. EPS improved significantly from last year, while sales saw a modest increase.
August 08, 2024 | 11:04 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
OptiNose reported better-than-expected EPS for Q2 2024, beating estimates by 37.5%, but missed sales estimates slightly. EPS showed significant improvement from last year, while sales increased modestly.
The better-than-expected EPS is a positive indicator for investors, suggesting improved profitability. The slight miss in sales is less concerning given the overall positive trend in earnings and sales growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100